Clinical Trial Update: MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1/2 clinical trial evaluating Mary Duol Repair Balm to prevent or reduce skin toxicity caused by antineoplastic agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatitis

Drugs mentioned

• MARY DUOL REPAIR BALM

Snippet

Sponsor: Basque Health Service | Conditions: Dermatitis, Adverse Drug Reaction | Phase 1, Phase 2 | Status: UNKNOWN